Prognostic significance of pre-treatment serum Cyfra21-1 as a tumor marker in patients with oropharyngeal squamous cell carcinoma treated with concurrent chemoradiotherapy

BACKGROUND: Oropharyngeal squamous cell carcinoma (OPSCC) is a kind of squamous cell carcinoma of head and neck, and its incidence is on the rise in recent years. A variety of prognostic markers for OPSCC have been reported in many studies, but they are expensive or difficult to obtain. So, we retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Liang, Liu, Guangping, Jin, Kai, Lu, Honglue, Zhai, Xiang, Zhou, Mengqian, Yue, Kai, Duan, Yuansheng, Wu, Yansheng, Wang, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661861/
https://www.ncbi.nlm.nih.gov/pubmed/33209882
http://dx.doi.org/10.21037/atm-20-6124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661861/
https://www.ncbi.nlm.nih.gov/pubmed/33209882
http://dx.doi.org/10.21037/atm-20-6124

Ejemplares similares